Editorial

DOI: 10.4244/EIJ-E-24-00038

Impella – a treatment for all STEMI patients with cardiogenic shock? The effect of off-hours admission

Thomas Engstrøm1, MD, DMSc, PhD; Jasmine Melissa Madsen1, MD

Prompt reperfusion is pivotal for improving prognosis in patients with ST-segment elevation myocardial infarction (STEMI)1. Thus, admission and revascularisation of patients with STEMI occur 24/7, owing to the unpredictable and acute nature of the disease. Yet, the time of admission may entail considerable significance for prognosis, a phenomenon called the off-hours effect2. The term refers to patients admitted at night or at weekends, and contemporary data suggest a worse prognosis for off-hours admissions compared to on-hours2. Intuitively, this tendency may be further accentuated in the most severe and acute STEMI cases, namely those in cardiogenic shock (CS).

CS is the most severe presentation of STEMI and bears a 50% mortality rate1. It is characterised by tissue hypoperfusion owing to myocardial ischaemia and subsequent left ventricular dysfunction. Consequently, the use of mechanical circulatory support (MCS) to ensure haemodynamic stability through the unloading of the left ventricle has been of great interest. Until recently, randomised trials evaluating various MCS devices have failed to show prognostic benefit in STEMI complicated by CS1. Yet, the newly published Danish Cardiogenic...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 16
Aug 19, 2024
Volume 20 Number 16
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV11I5A99 Sep 22, 2015
Time, space and leaps of faith
Dauerman H
free

Editorial

10.4244/EIJ-E-24-00032 Jun 17, 2024
Therapeutic hypothermia to reduce infarct size in STEMI: time to give it the cold shoulder?
Hausenloy DJ and Bulluck H
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved